• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. ESPRIT¿; STENT, INFRAPOPLITEAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. ESPRIT¿; STENT, INFRAPOPLITEAL, ABSORBABLE Back to Search Results
Model Number 1203375-38
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Obstruction/Occlusion (2422)
Date of Event 01/22/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported the procedure on (b)(6) 2024 was to treat a lesion in the right proximal peroneal artery.The lesion was treated with an auryon laser and 4.0 shockwave to less than 30% residual stenosis.The 3.75x38mm esprit btk scaffold was implanted without issue.The patient returned at a follow up visit complaining of foot pain.Occlusion was noted proximal to the scaffold, extending through the scaffold to approximately 30 mm distal of the scaffold.Right lower extremity revascularization was performed as treatment on (b)(6) 2025.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.The reported patient effects of pain and occlusion are listed in the esprit btk everolimus eluting resorbable scaffold system instructions for use as known patient effects of coronary scaffolding procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESPRIT¿
Common Device Name
STENT, INFRAPOPLITEAL, ABSORBABLE
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key21293803
Report Number2024168-2025-01210
Device Sequence Number18079273
Product Code NXW
UDI-Device Identifier08717648357176
UDI-Public(01)08717648357176(17)250610(10)4061161
Combination Product (Y/N)Y
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P230036
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/03/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/10/2025
Device Model Number1203375-38
Device Catalogue Number1203375-38
Device Lot Number4061161
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/22/2025
Initial Report FDA Received Date02/03/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/11/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age72 YR
Patient SexMale
-
-